XML 75 R65.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENTS - RELATED PARTIES (Details 1) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Fair value of derivative instruments issued by AVLP $ 10,184 $ (946,825) $ 5,773 $ (946,825)  
Avalanche International Corp. ("AVLP") and Alzamend Neuro, Inc. ("Alzamend") [Member]          
Investment in common stock of AVLP and Alzamend     575,925   $ 558,938
Avalanche International Corp. ("AVLP") and Alzamend Neuro, Inc. ("Alzamend") [Member] | Warrants and Common Stock [Member]          
Balance at beginning     2,128,224    
Investment in convertible promissory notes of AVLP        
Investment in common stock of AVLP and Alzamend     12,884    
Fair value of derivative instruments issued by AVLP     9,093    
Unrealized loss in derivative instruments of AVLP     (481,213)    
Unrealized loss in common stock of AVLP and Alzamend     (64,639)    
Balance at end 1,604,349   1,604,349   2,128,224
Avalanche International Corp. [Member] | 8% Convertible Promissory Note [Member]          
Balance at beginning     6,540,720    
Investment in convertible promissory notes of AVLP     198,514    
Investment in common stock of AVLP and Alzamend        
Fair value of derivative instruments issued by AVLP        
Unrealized loss in derivative instruments of AVLP        
Unrealized loss in common stock of AVLP and Alzamend        
Balance at end 6,739,234   6,739,234   6,540,720
Avalanche International Corp. ("AVLP") and Alzamend Neuro, Inc. ("Alzamend") [Member]          
Balance at beginning     8,668,944    
Investment in convertible promissory notes of AVLP     198,514    
Investment in common stock of AVLP and Alzamend     12,884    
Fair value of derivative instruments issued by AVLP     9,093    
Unrealized loss in derivative instruments of AVLP     (481,213)    
Unrealized loss in common stock of AVLP and Alzamend     (64,639)    
Balance at end $ 8,343,583   $ 8,343,583   $ 8,668,944